GN Store Nord (GN) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
13 Nov, 2025Executive summary
Achieved 1% organic revenue growth (excluding wind-down), led by strong performance in Hearing and Gaming, while Enterprise faced challenges due to EMEA market uncertainty; reported organic growth was -1% due to wind-down effects.
EBITA margin was 11% in Q3 2025, down from 13.3% in Q3 2024, with free cash flow (excl. M&A) of DKK 410 million, reflecting strong cost focus and operational execution.
Leverage improved to 4.0x from 4.3x year-over-year, supported by new financing arrangements and healthy cash flow.
Recent product launches (Vivia, Enzo, Arctis Nova Elite) received positive market feedback and are expected to support future growth.
Financial highlights
Group revenue for Q3 2025 was DKK 4,060 million, with gross profit at DKK 2,155 million and gross margin of 54.4%, down 0.4pp year-over-year.
EBITA was DKK 435 million, margin at 11.0%; free cash flow (excl. M&A) was DKK 410 million, driven by earnings and working capital improvements.
Net interest-bearing debt decreased to DKK 9.4 billion, leverage at 4.0x.
Divisional profit margins: Hearing 34.2%, Enterprise 33.8%, Gaming 8.6% (excluding wind-down).
Earnings per share (EPS) was DKK 0.50 (Q3 2024: DKK 1.86); equity ratio at 29%.
Outlook and guidance
2025 guidance confirmed: organic revenue growth (excluding wind-down) of -2% to +2%, EBITA margin of 11–13%, and free cash flow (excl. M&A) of DKK 800 million.
Wind-down expected to negatively impact reported organic revenue growth by approximately 3 percentage points.
Management expects gradual improvement in Enterprise and continued strong performance in Hearing into Q4.
Latest events from GN Store Nord
- Hearing business sold to Amplifon for DKK 17B, enabling tech focus and global audiology leadership.GN
M&A announcement16 Mar 2026 - Guiding for 3%-7% organic growth and margin expansion in 2026, led by innovation and cost control.GN
Q4 20255 Feb 2026 - Pursuing margin expansion and growth through innovation in hearing, enterprise, and gaming.GN
SEB Nordic Seminar presentation5 Feb 2026 - 5% organic growth and margin gains, with strong Hearing and Gaming, guidance confirmed.GN
Q2 202423 Jan 2026 - Record cash flow and margin gains as Hearing outperformed, offsetting mixed divisional growth.GN
Q3 202416 Jan 2026 - Strong EBITDA growth, new board members, and strategic focus on innovation and resilience.GN
AGM 202520 Dec 2025 - Strong 2024 growth and margin gains set the stage for further expansion in 2025.GN
Q4 202417 Dec 2025 - Organic revenue fell 3%, but margin gains and new launches support cautious optimism.GN
Q1 202529 Nov 2025 - EBITA up 46% on margin gains, with Hearing strong and 2025 guidance narrowed amid tariff risks.GN
Q2 202523 Nov 2025